CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
S-adenosyl methioninedrug
Likely dose
S-adenosyl methionine 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00694564
NCT00694564N/ACompleted
CompareCT.gov

A Pilot Open-labeled Trial of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children

Huang, Jeannie, M.D.·interventional·Posted Jun 10, 2008·Updated Mar 16, 2018

In Brief

A clinical study evaluating S-adenosyl methionine for Abdominal Pain. Completed, enrolled 8 participants across 1 site.

Detailed Summary

This pilot study will investigate the efficacy of SAM-e for the treatment of recurrent abdominal pain in children. This will be an open-labeled study and all participants will receive SAM-e therapy. Given that SAM-e has been demonstrated to improve symptoms of depression and pain with minimal side effects as compared to other antidepressant therapy, we hypothesize that SAM-e will reduce pain symptoms among children with recurrent abdominal pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 10, 2008
Enrollment StartJun 1, 2007
Primary CompletionMar 1, 2011
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 18.1 years ago

Interventions

S-adenosyl methioninedrug

S-adenosyl methionine will be dosed as 200 mg tablets with doses ranging from 200 to 1400 mg daily.